This inventor holds 1 USPTO granted patent. Top assignee: Leiras Oy. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Marko Ahlmark: Innovator in Pharmaceutical Chemistry
Introduction
Marko Ahlmark is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on methylenebisphosphonic acid derivatives. His research has the potential to impact various pharmaceutical applications.
Latest Patents
Marko Ahlmark holds a patent for "Methylenebisphosphonic acid derivatives." This invention focuses on novel halogen substituted methylenebisphosphonic acid anhydrides, ester anhydrides, amide anhydrides, and ester amide anhydrides. The patent also includes processes for the preparation of these novel compounds, as well as pharmaceutical preparations that incorporate them.
Career Highlights
Marko Ahlmark is associated with Leiras Oy, a company known for its contributions to the pharmaceutical industry. His work at Leiras Oy has allowed him to explore and develop innovative solutions in drug formulation and development.
Collaborations
Throughout his career, Marko has collaborated with esteemed colleagues such as Esko Pohjala and Heikki Nupponen. These collaborations have fostered a productive environment for research and innovation.
Conclusion
Marko Ahlmark's contributions to pharmaceutical chemistry through his patent on methylenebisphosphonic acid derivatives highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile